Philip Morris International (PMI) this week submitted its iQOS technology for approval as a reduced-risk product by the U.S. Food and Drug Administration (FDA), a strategy which if successful would provide a tremendous boost to the credibility of heat-not-burn and perhaps pave the way for PMI’s partner Altria to dominate that market in the United States. ...
Restricted content. Do you want to read more?
Sign up NOW for 7 days FREE TRIAL and access our briefings section
All you need to know to succeed in the Chinese market
New exclusive report: E-cigarettes in China: market, regulation and outlook
Looking for market trends and commercial opportunities in one of the fastest-growing e-cigarette markets in the world? If you want to identify the latest trends developing in the Chinese e-cigarette market, and ensure that products and business activities are fully compliant with Chinese regulation, then this new report is for you!